APIXABAN FORMULATIONS

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Holdings Ireland Unlimited Company;Pfizer Inc.

发明人:

Patel, Jatin,Frost, Charles,Jia, Jingpin,Vema-Varapu, Chandra

申请号：

AU2017228681

公开号：

AU2017228681B2

申请日:

2017.09.15

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

#$%^&*AU2017228681B220190718.pdf#####ABSTRACT Compositions comprising crystalline apixaban particles having a D 9 0 equal to or less than 89 pm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/